Federal contract award
75N91018F00005
IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541711 |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | HHSN261201500024I |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.0M |
| Current contract value | $2.0M |
| Potential contract value / ceiling | $2.0M |
| Start date | Sep 17, 2018 |
| Current end date | Jul 25, 2025 |
| Potential end date | Jul 25, 2025 |
| Latest award activity | Dec 2, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 2, 2025 | P00013 | $-96 | FY26 UDO INITIATIVE - LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL. |
| Jul 30, 2025 | P00012 | $0 | LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL. |
| Mar 12, 2025 | P00011 | $0 | LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL. |
| Dec 10, 2024 | P00010 | $0 | LFA (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.